Leadership

Eun Ju Ryu President

Eun Ju Ryu received her Bachelor’s degree in Pharmacy at Ewha Womans University, Master’s in Clinical Pharmacy at Sookmyung Women’s University, and MBA degree at New York University in the US. Her 30 years career started as a Regulatory manager, then expanded roles in several companies as a Clinical Trial Management team lead and Marketing team lead. While she was working as a Head of Oncology and Specialty Business Unit at Pfizer Korea, she got promoted as a Japan Asia Regional Commercial lead based in New York headquarter in 2006. Once moved to the US, she was leading Global Marketing and Portfolio Maximization and Acquisition in various therapeutic areas including Oncology, Rare Disease, Anti-Infectives, and Neuroscience. She was awarded by the Korean Minister of Health and Welfare for her contribution in US-Korea collaboration, and later received Asian MBA leader’s award as well. Her continuous community service has been recognized by the Bergen County Community leadership award. She also worked as a CEO of Korean Community Center and a Chief Business Development Officer in Diagnostic Company. Eun-Ju joins as President, Samyang Biopharm USA in end of Jan. 2022.

Helen Cho, Ph.D. Head of R&D

After earning her Bachelor’s degree from the Department of Biochemistry, Yonsei University and her Master’s degree in bioengineering from KAIST, Dr. Helen Cho acquired her PhD degree in molecular biology and biochemistry from the University of Medicine and Dentistry of New Jersey. Then, she completed her post-doctorate program at Salk Institute and joined Pfizer, a global pharmaceutical company, where she led the development of anticancer immunotherapy drugs based on combination therapy by using her experiences in various fields covering biological carriers and antibodies. As an Associate Research Fellow, she oversaw the research and development (R&D) of anticancer vaccines and oncolytic virus-based immunotherapy drugs as well as early clinical trials. Currently, she serves as the Director of Samyang Holdings Biopharmaceuticals Division R&D Center, supervising R&D in pharmaceuticals, biologics and MD businesses.

Scientific Advisory Board

Louis M. Weiner

Professor and Chairman
Department of Oncology Georgetown University Medical Center

Director
Lombardi Comprehensive Cancer Center Georgetown University Medical Center

Thomas F. Gajewski

AbbVie Foundation Professor
Cancer Immunotherapy, Departments of Pathology, Medicine and the Ben May Department for Cancer Research

University of Chicago